A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD

Completed · Phase 3

Conditions studied: Chronic Obstructive Pulmonary Disease

In brief

The purpose of this study is to compare Symbicort in a pressurized metered-dose inhaler (pMDI) with formoterol and placebo in the long-term maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Key facts

Study ID

NCT00206167

Run by

AstraZeneca

People needed

1600

Starts

2005-04-01

Expected to finish

2007-09-01

Last updated by the study team

2009-03-27

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A clinical diagnosis of COPD with symptoms for more than 2 years.
• Smoking history of 10 or more pack years
• A history of at least one COPD exacerbation requiring a course of oral steroids and/or antibiotics within 1-12 months before first visit.

You may not qualify if…

• A history of asthma
• Patients taking oral steroids
• Any significant disease or disorder that may jeopardize the safety of the patient

Where it is running

• Research Site — Huntsville, Alabama, United States
• Research Site — Jasper, Alabama, United States
• Research Site — Muscle Shoals, Alabama, United States
• Research Site — Mesa, Arizona, United States
• Research Site — Phoenix, Arizona, United States
• Research Site — Tucson, Arizona, United States
• Research Site — Fort Smith, Arkansas, United States
• Research Site — Carmichael, California, United States
• Research Site — La Jolla, California, United States
• Research Site — Lakewood, California, United States
• Research Site — Los Angeles, California, United States
• Research Site — Murrieta, California, United States
• Research Site — Palo Alto, California, United States
• Research Site — Peninsula, California, United States
• Research Site — Pismo Beach, California, United States
• Research Site — Rancho Mirage, California, United States
• Research Site — Riverside, California, United States
• Research Site — Sacramento, California, United States
• Research Site — San Diego, California, United States
• Research Site — Santa Ana, California, United States
• Research Site — Stockton, California, United States
• Research Site — Walnut Creek, California, United States
• Research Site — Colorado Springs, Colorado, United States
• Research Site — Hartford, Connecticut, United States
• Research Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.